'It was announced on Tuesday that Merck will pay upwards of $950 million as a means of resolving investigations carried out regarding the company’s marketing tactics of their painkiller Vioxx.
The corrupt, profit-driven company is planning to pay $321.6 million in criminal fines while the remaining $628.4 million goes toward a civil settlement agreement.
Merck will also be pleading guilty to a misdemeanor charge due to false advertising and deceptive marketing tactics by marketing Vioxx as a treatment for rheumatoid arthritis – all without FDA approval. While the amount of money Merck must pay may seem rather large, the company makes billions of dollars selling their disease-riddled products.'
No comments:
Post a Comment